U.K. Policy Researchers Fear Ministry Censors

London - A new government policy has brought into sharp focus a simmering row between British academics and the Department of Health and Social Security on the integrity of their research findings. The immediate problem stems from new contract language specifying that publication of findings "is subject to the proper consent of the secretary of state, which consent shall not be unreasonably withheld." Under the terms of the old contract, which covers social policy research commissioned by the

Written byMelanie Phillips
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The immediate problem stems from new contract language specifying that publication of findings "is subject to the proper consent of the secretary of state, which consent shall not be unreasonably withheld." Under the terms of the old contract, which covers social policy research commissioned by the DHSS, department officials had a period of time to comment upon the findings but were unable to alter the findings or block publication. Not surprisingly, researchers feel that the new terms invite political censorship, and they are unwilling to believe assurances given to them by the DHSS that this will not occur. Many heads of research units icy has brought into sharp focus a are accordingly refusing to sign the new contract.

Last month Health Minister Tony Newton appeared before a committee of the House of Lords to try to allay such fears. He told them that the change was done purely 'for legal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies